To: Board of Supervisors
From: Dr. Ori Tzvieli, Interim Health Services Director
Report Title: Purchase Order with Becton Dickinson and Company
☒Recommendation of the County Administrator ☐ Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Interim Health Services Director, a blanket purchase order with Becton Dickinson and Company (BD) in an amount not to exceed $199,000 and a BD Acquisition Agreement for the rental of the SlidePrep and PrepMate instruments, and the purchase of service, preventive maintenance, accessories, and consumables for the Contra Costa Regional Medical Center (CCRMC) effective the date of last signature and for three years thereafter.
FISCAL IMPACT:
Approval of this action will result in expenditures of up to $199,000 over a three-year period and will be funded by Hospital Enterprise Fund I revenues.
BACKGROUND:
BD is a global medical technology company that develops, manufactures, and sells medical devices, laboratory equipment, and diagnostic solutions. BD specializes in areas such as medication management, infection prevention, diagnostics, biosciences, and surgical solutions. Their products include syringes, needles, catheters, blood collection systems, infusion pumps, and automated diagnostic instruments. BD serves hospitals, laboratories, and research institutions worldwide, focusing on improving patient safety, healthcare efficiency, and disease management.
The BD SlidePrep and BD PrepMate, developed by Becton Dickinson and Company (BD), are laboratory instruments designed to streamline specimen preparation for diagnostic testing. The BD SlidePrep automates slide preparation and staining, ensuring consistent, high-quality specimen slides for microbiology and cytology. The BD PrepMate serves as a specimen processing workstation, standardizing sample preparation to reduce manual handling and improve diagnostic accuracy. Together, these instruments enhance efficiency, consistency, and accuracy in laboratory workflows, contributing to better diagnostic outcomes.
The agreement includes mutual indemnification for any loss, damages or liability from any third party claim to the extent arising from the indemnifying party’s negligence or willful misconduct, and breach of its representations under the agreement. Becton Dickinson and Company’s liability under this agreement is limited to the amount of all fees paid or to be paid by the County under the customer order(s) to which the matter relates during the twelve-month period immediately preceding the event giving rise to such liability. Neither party will be liable to the other party for (I) any incidental, indirect, special, consequential, or punitive damages (II) any damages for business interruption, or (III) re-procurement costs, loss of profits, income, business, use, data or goodwill.
On February 25, 2020, the Board of Supervisors approved agenda item C.48 to execute a purchase order with Becton Dickinson and Company in the amount of $271,872 for the period of April 1, 2020, through March 31, 2025.
Approval of this request will maintain workflow efficiency, reduce errors, and support timely, reliable diagnostic results for improved patient care. This purchase will be made via sole source justification, for product and service continuity.
CONSEQUENCE OF NEGATIVE ACTION:
If this action is not approved, CCRMC may face delays, increased errors, and reduced diagnostic accuracy due to manual specimen processing. This could impact workflow efficiency, timely diagnoses, and patient care.